Rapid Dose Therapeutics Corp. (CSE:DOSE)
Canada
· Delayed Price · Currency is CAD 0.155
-0.005 (-3.13%)
Dec 5, 2025, 9:30 AM EST
Rapid Dose Therapeutics Revenue
Rapid Dose Therapeutics had revenue of 672.92K CAD in the quarter ending August 31, 2025, with 30.43% growth. This brings the company's revenue in the last twelve months to 2.63M, up 95.76% year-over-year. In the fiscal year ending February 28, 2025, Rapid Dose Therapeutics had annual revenue of 2.09M with 104.34% growth.
Revenue (ttm)
2.63M
Revenue Growth
+95.76%
P/S Ratio
7.88
Revenue / Employee
n/a
Employees
n/a
Market Cap
20.69M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Curaleaf Holdings | 1.78B |
| dentalcorp Holdings | 1.66B |
| Green Thumb Industries | 1.61B |
| Sienna Senior Living | 967.05M |
| Extendicare | 1.59B |
| Trulieve Cannabis | 1.66B |
| Cronos Group | 184.36M |
| WELL Health Technologies | 1.25B |